Mirabegron is a monocarboxylic acid amide derived from 2-amino-1,3-thiazol-4-ylacetic acid and a substituted phenylethanolamine. It functions as a beta-3 adrenergic agonist and is used as an active pharmaceutical ingredient in the manufacturing of medications for overactive bladder syndrome.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 223673-61-8
2-(2-Amino-1,3-thiazol-4-yl)-N-(4-(2-((2-phenylethyl)amino)ethyl)phenyl)acetamide
pharmaceutical raw material
2-Oxo Mirabegron
pharmaceutical raw material
Acalabrutinib maleate
pharmaceutical raw material
Ginsenoside Rg1
pharmaceutical raw material
Acoramidis hydrochloride
pharmaceutical raw material
Retapamulin
pharmaceutical raw material
(S)-Mirabegron
pharmaceutical raw material
N-Nitroso Mirabegron
research compound
2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide
PBAPPPCECJKMCM-IBGZPJMESA-N
C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O